Richard F Little

Richard F Little

UNVERIFIED PROFILE

Are you Richard F Little?   Register this Author

Register author
Richard F Little

Richard F Little

Publications by authors named "Richard F Little"

Are you Richard F Little?   Register this Author

73Publications

-Reads

Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research HIV Working Group.

J Clin Oncol 2017 Nov 2;35(33):3774-3780. Epub 2017 Oct 2.

Thomas S. Uldrick and Richard F. Little, National Cancer Institute, Bethesda; Gwynn Ison and Barry Miller, US Food and Drug Administration, Silver Spring; Michelle A. Rudek, Johns Hopkins University, Baltimore, MD; Ariela Noy, Memorial Sloan Kettering Cancer Center and Weill Medical College, New York, NY; Karl Schwartz, Patients Against Lymphoma, Riegelsville, PA; Suanna Bruinooge and Caroline Schenkel, ASCO, Alexandria, VA; Kieron Dunleavy, George Washington University, Washington, DC; Judy Wang, Florida Cancer Specialists and Research Institute, Sarasota, FL; and Jerome Zeldis, Sorrento Therapeutics, San Diego, CA.

View Article
November 2017

Myeloma Minimal Residual Disease and Surrogacy.

JAMA Oncol 2017 Aug;3(8):1136

Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Rockville, Maryland.

View Article
August 2017

Checking up on checkpoint inhibitors.

Blood 2017 07;130(2):107-108

NATIONAL INSTITUTES OF HEALTH.

View Article
July 2017

Hodgkin Lymphoma: Current Status and Clinical Trial Recommendations.

J Natl Cancer Inst 2017 04 31;109(4). Epub 2016 Dec 31.

Affiliations of authors: NYU Perlmutter Cancer Center, New York, NY (CSD); BC Cancer Agency Centre for Lymphoid Cancer, Vancouver, BC, Canada (JMC); Wilmot Cancer Center and Division of Hematology/Oncology, University of Rochester Medical Center, Rochester, NY (JWF); Department of Medicine, Weil Cornell University, New York, NY (JPL); Oncology Division, Department of Medicine, Washington University, St. Louis, MO (BSK, NLB); Division of Cancer Treatment and Diagnosis (RFL) and Coordinating Center for Clinical Trials (LB), Tufts Cancer Center and Division of Hematology/Oncology, Tufts University School of Medicine, Boston, MA (AME); Stanford Cancer Institute, Stanford University Medical School, Stanford, CA (RTH); Division of Pediatric Hematology/Oncology/Stem Cell Transplant, Columbia University Medical Center, New York, NY (KMK); Department of Medicine, University of Arizona Cancer Center, Tucson, AZ (DOP); Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY (AY); Department of Radiology, Mount Sinai Hospital, New York, NY (LK).

View Article
April 2017

Recommendations for Clinical Trial Development in Follicular Lymphoma.

J Natl Cancer Inst 2017 03 31;109(3). Epub 2016 Dec 31.

Affiliations of authors: The Ohio State University, Columbus, OH (KM); University of Rochester Medical Center, Rochester, NY (PMB); Georgetown University Hospital, Washington, DC (BDC); Division of Cancer Treatment and Diagnosis (RFL) and Coordinating Center for Clinical Trials (LB), National Cancer Institute, Bethesda, MD; Department of Medicine, Oncology Division, Washington University, St. Louis, MO (BSK); Department of Medicine, Weil Cornell University, New York, NY (JPL); The University of Texas MD Anderson Cancer Center, Houston, TX (NF); Northwestern University, Chicago, IL (LIG); University of Iowa, Iowa City, IA (BKL); Wilmot Cancer Center and Division of Hematology/Oncology, University of Rochester, Rochester, NY (JWF); Mayo Clinic, Rochester, MN (SMA).

View Article
March 2017

Cancer clinical trials in persons with HIV infection.

Authors:
Richard F Little

Curr Opin HIV AIDS 2017 01;12(1):84-88

Head, Blood and AIDS-related Cancer Therapeutics, Clinical Investigations Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

View Article
January 2017

Recommendations for Clinical Trial Development in Mantle Cell Lymphoma.

J Natl Cancer Inst 2017 01 31;109(1). Epub 2016 Dec 31.

Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.

View Article
January 2017

Update on Burkitt Lymphoma.

Hematol Oncol Clin North Am 2016 Dec;30(6):1333-1343

Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.

View Article
December 2016

Measure for measure: minimal residual disease in CLL.

Blood 2016 12;128(24):2747-2748

NATIONAL INSTITUTES OF HEALTH.

View Article
December 2016

General Biomarker Recommendations for Lymphoma.

J Natl Cancer Inst 2016 Dec 16;108(12). Epub 2016 Dec 16.

Department of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, AZ (LR), Department of Pathology and Laboratory Medicine, University of North Carolina Medical School, Chapel Hill, NC (YF), Center for Cancer Research, National Cancer Institute, Bethesda, MD (LMS), Department of Medicine, Weill Cornell Medical College, New York, NY (AM), Department of Pathology and Laboratory Medicine, British Columbia Cancer Agency, Vancouver, BC, Canada (RG), Clinical Cancer Research Unit, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada (MC), Coordinating Center for Clinical Trials, National Cancer Institute, Bethesda, MD (LB), Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE (KF), Department of Pathology and Laboratory Medicine, Cleveland Clinic Foundation, Cleveland, OH (ED), Department of Pathology, City of Hope Medical Center, Duarte, CA (JWCC), Biometrics Research Branch, National Cancer Institute, Bethesda, MD (LM), Department of Medicine, Weill Cornell Medicine, New York, NY (JPL), Department of Medicine, Oncology Division, Washington University, St. Louis, MO (BSK), Clinical Investigations Branch, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD (RFL), Wilmot Cancer Center and Division of Hematology/Oncology, University of Rochester, Rochester, NY (JWF), Department of Radiology, Mount Sinai Medical Center New York, NY (LK).

View Article
December 2016

Beyond RCHOP: A Blueprint for Diffuse Large B Cell Lymphoma Research.

J Natl Cancer Inst 2016 12 16;108(12). Epub 2016 Dec 16.

Department of Medicine, Mayo Clinic, Rochester, MN (GSN); Department of Internal Medicine, Ohio State University, Columbus, OH (KAB); Department of Medicine, Oncology Division, Washington University, St. Louis, MO (BSK); Wilmot Cancer Center and Division of Hematology/Oncology, University of Rochester, Rochester, NY (JWF); Coordinating Center for Clinical Trials (LB), Division of Cancer Treatment and Diagnosis (RFL), and Center for Cancer Research (WHW), National Cancer Institute, National Institute of Health, Bethesda, MD; Division of Oncology, University of Washington, Seattle WA (DGM); British Colombia Cancer Agency, Vancouver, BC (LHS); Department of Medicine, University of Virginia, Charlottesville, VA (MEW); Department of Medicine, Weil Cornell University, New York, NY (JPL); Department of Medicine, University of Chicago, Chicago, IL (SMS).

View Article
December 2016

Design Issues in Randomized Clinical Trials of Maintenance Therapies.

J Natl Cancer Inst 2015 Nov 18;107(11). Epub 2015 Aug 18.

Biometric Research Branch (BF, ELK) and Clinical Investigations Branch, Cancer Therapy Evaluation Program (RFL), Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD.

View Article
November 2015

How I treat classical Hodgkin lymphoma in patients infected with human immunodeficiency virus.

Blood 2015 Feb 11;125(8):1226-35; quiz 1355. Epub 2014 Dec 11.

HIV and AIDS Malignancy Branch, Center for Cancer Research, and Clinical Investigations Branch, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD.

View Article
February 2015

Paradoxical central nervous system immune reconstitution syndrome in acquired immunodeficiency syndrome-related primary central nervous system lymphoma.

Haematologica 2015 Jan 10;100(1):e21-4. Epub 2014 Oct 10.

HIV & AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute; National Institutes of Health

View Article
January 2015

Treatment of de novo acute myeloid leukemia in the United States: a report from the Patterns of Care program.

Leuk Lymphoma 2014 Nov 7;55(11):2549-55. Epub 2014 Mar 7.

National Cancer Institute , Bethesda, MD , USA.

View Article
November 2014

Update on the treatment of HIV-associated hematologic malignancies.

Hematology Am Soc Hematol Educ Program 2013 ;2013:382-8

1National Cancer Institute, National Institutes of Health, Bethesda, MD.

View Article
July 2014

The rising challenge of non-AIDS-defining cancers in HIV-infected patients.

Clin Infect Dis 2012 Nov 9;55(9):1228-35. Epub 2012 Jul 9.

Division of Hematology/Oncology, Georgetown University Medical Center, 3800 Reservoir Rd NW, Washington, DC 20007, USA.

View Article
November 2012

Characterization of immune responses to capsid protein p24 of human immunodeficiency virus type 1 and implications for detection.

Clin Vaccine Immunol 2010 Aug 9;17(8):1244-51. Epub 2010 Jun 9.

Lab of Molecular Virology, Center for Biologics Evaluation and Research, Food and Drug Administration, 8800 Rockville Pike, Bethesda, MD 20892, USA.

View Article
August 2010

Novel disease targets and management approaches for diffuse large B-cell lymphoma.

Leuk Lymphoma 2010 Aug;51 Suppl 1:1-10

Metabolism Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.

View Article
August 2010

Distinct profiles of antibodies to Kaposi sarcoma-associated herpesvirus antigens in patients with Kaposi sarcoma, multicentric Castleman disease, and primary effusion lymphoma.

J Infect Dis 2010 Jun;201(12):1919-22

Neurobiology and Pain Therapeutics Section, Laboratory of Sensory Biology, National Institute of Dental and Craniofacial Research, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.

View Article
June 2010

Neutrophil count in African Americans: lowering the target cutoff to initiate or resume chemotherapy?

J Clin Oncol 2010 Apr 1;28(10):1633-7. Epub 2010 Mar 1.

Molecular and Clinical Hematology Branch, National Institute of Diabetes, Digestive, and Kidney Diseases, National Heart, Lung, and Blood Institute, Bethesda, MD, USA.

View Article
April 2010

AIDS, T cells, chemotherapy: HAART-breaking?

Authors:
Richard F Little

Blood 2008 Apr;111(8):3921-2

National Cancer Institute, USA.

View Article
April 2008

Including persons with HIV infection in cancer clinical trials.

J Clin Oncol 2008 Mar;26(7):1027-32

Department of Bioethics, The Clinical Center, The Clinical Investigations Branch, Cancer Therapy Evaluation Program, Division of Cancer Therapy and Diagnosis, National Cancer Institute, The National Institutes of Health, Bethesda, MD, USA.

View Article
March 2008

Treatment of AIDS-related Kaposi's sarcoma with interleukin-12: rationale and preliminary evidence of clinical activity.

Crit Rev Immunol 2007 ;27(5):401-14

HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892-1868, USA.

View Article
February 2008

Using noninvasive multispectral imaging to quantitatively assess tissue vasculature.

J Biomed Opt 2007 Sep-Oct;12(5):051604

National Institutes of Health, National Institute of Child Health and Human Development, Laboratory of Integrative and Medical Biophysics, Bethesda, Maryland 20892, USA.

View Article
January 2008

Phase 2 study of pegylated liposomal doxorubicin in combination with interleukin-12 for AIDS-related Kaposi sarcoma.

Blood 2007 Dec 10;110(13):4165-71. Epub 2007 Sep 10.

HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892-1868, USA.

View Article
December 2007

Conservation of virally encoded microRNAs in Kaposi sarcoma--associated herpesvirus in primary effusion lymphoma cell lines and in patients with Kaposi sarcoma or multicentric Castleman disease.

J Infect Dis 2007 Mar 23;195(5):645-59. Epub 2007 Jan 23.

Viral Epidemiology Section, AIDS Vaccine Program, Science Applications International Corporation-Frederick, National Cancer Institute-Frederick, Frederick, MD 21701, USA.

View Article
March 2007

Acquired immunodeficiency syndrome-related malignancies in the era of highly active antiretroviral therapy.

Int J Hematol 2006 Jul;84(1):3-11

HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland 20892-1868, USA.

View Article
July 2006

Activity of subcutaneous interleukin-12 in AIDS-related Kaposi sarcoma.

Blood 2006 Jun 28;107(12):4650-7. Epub 2006 Feb 28.

HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-1868, USA.

View Article
June 2006

Therapy insight: AIDS-related malignancies--the influence of antiviral therapy on pathogenesis and management.

Nat Clin Pract Oncol 2005 Aug;2(8):406-15; quiz 423

HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-1868, USA.

View Article
August 2005

AIDS-related non-Hodgkin's lymphoma: etiology, epidemiology, and impact of highly active antiretroviral therapy.

Authors:
Richard F Little

Leuk Lymphoma 2003 ;44 Suppl 3:S63-8

HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, Bldg 10, Room 10S255, 9000 Rockville Pike, Bethesda, MD 20892-1868, USA.

View Article
October 2004

Fluorodeoxyglucose positron emission tomography in the presence of cardiac metastases.

Clin Nucl Med 2003 Dec;28(12):979-80

Department of Nuclear Medicine, Warren Grant Magnuson Clinical Center, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article
December 2003

Update on the Pathogenesis, Diagnosis, and Therapy of AIDS-related Lymphoma.

Curr Infect Dis Rep 2003 Apr;5(2):176-184

*HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Building 10, Room 10S255, 10 Center Drive MSC 1868, Bethesda, MD 20892-1868, USA.

View Article
April 2003

Treatment of gammaherpesvirus-related neoplastic disorders in the immunosuppressed host.

Semin Hematol 2003 Apr;40(2):163-71

HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article
April 2003

Update on Kaposi's Sarcoma: A Gammaherpesvirus- induced Malignancy.

Curr Infect Dis Rep 2003 Feb;5(1):85-92

HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 10 Center Drive, MSC 1868, Building 10, Room 10S255, Bethesda, MD 20892-1868, USA.

View Article
February 2003